IAPP
AIGP · Question #24
AIGP Question #24: Real Exam Question with Answer & Explanation
Sign in or unlock AIGP to reveal the answer and full explanation for question #24. The question stem and answer options stay visible for context.
Question
You are the chief privacy officer of a medical research company that would like to collect and use sensitive data about cancer patients, such as their names, addresses, race and ethnic origin, medical histories, insurance claims, pharmaceutical prescriptions, eating and drinking habits and physical activity. The company will use this sensitive data to build an AI algorithm that will spot common attributes that will help predict if seemingly healthy people are more likely to get cancer. However, the company is unable to obtain consent from enough patients to sufficiently collect the minimum data to train its model. Which of the following solutions would most efficiently balance privacy concerns with the lack of available data during the testing phase?
Options
- ADeploy the current model and recalibrate it over time with more data.
- BExtend the model to multimodal ingestion with text and images.
- CUtilize synthetic data to offset the lack of patient data.
- DRefocus the algorithm to patients without cancer.
Unlock AIGP to see the answer
You've previewed enough free AIGP questions. Unlock AIGP for full answers, explanations, the timed quiz mode, progress tracking, and the master PDF. Question stem and options stay visible so you can still see what's on the exam.